Register for free to
view the full innovation profile.
Ref: 06871
Treatment of Biofilm Infection
Enzymatic Pyruvate Depletion as Adjunctive Therapy for Treatment
Enzymatically driven pyruvate-depleting conditions enhance the ability of antimicrobial agents and/or the immune system to control the growth of microorganisms
About
This technology utilizes a new approach to modulating the extracellular metabolites of biofilm cells to enhance the ability of antimicrobial agents and/or the immune system to control the growth and persistence of microorganisms in medical settings and aqueous systems.
Key Benefits
Biodegradable. Non-toxic. Approach capable of targeting resistant biofilm cells. Mechanism of action and experimental data suggest very low likelihood of the emergence of resistance. Can be used synergistically with other antimicrobials and dispersion-inducing compounds.